ACORN CAPITAL ADVISORS, LLC
Filing Date
Global Rank
#3,371
/ 8,700
▲ 1802
Top Industry
Biotechnology
100.0%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
7 quarters · since Dec 2024
Portfolio Concentration
20 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
21.9%
−7.5 pts
Top 5
68.6%
+1.0 pts
Top 10
90.2%
+2.3 pts
HHI
1,177
Diversified−176
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $366,458,500 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | +1,230,287 | 1,518,113 | $14,831,964 | |
| AURA | Aura Biosciences, Inc. | +333,333 | 929,077 | $6,596,446 | |
| JBIO | Jade Biosciences, Inc. | +200,000 | 986,760 | $21,925,807 | |
| JSPR | Jasper Therapeutics, Inc. | +26,667 | 1,438,159 | $605,464 | |
| CGON | CG Oncology, Inc. | +999 | 1,131,500 | $80,393,075 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | 1,271,257 | $2,199,274 | |
| No positions match the current search. | ||||
20 tracked positions ·
$366,458,500 total
· filing declares
20 positions · $366,457,132
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 1,131,500 | $80,393,075 | 21.94% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 1,673,420 | $61,581,856 | 16.80% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 2,144,844 | $40,001,340 | 10.92% | |
| CADL |
Candel Therapeutics, Inc.
Healthcare
|
Held | 3,497,948 | $36,028,864 | 9.83% | |
| PBYI |
Puma Biotechnology, Inc.
Healthcare
|
Held | 4,131,299 | $33,504,834 | 9.14% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 986,760 | $21,925,807 | 5.98% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Reduced | 643,381 | $19,101,981 | 5.21% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Added | 1,518,113 | $14,831,964 | 4.05% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Held | 2,839,674 | $12,948,913 | 3.53% | |
| HELP |
Cybin Inc.
Healthcare
|
Held | 1,540,266 | $10,181,158 | 2.78% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Held | 1,752,115 | $6,693,079 | 1.83% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Added | 929,077 | $6,596,446 | 1.80% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 634,539 | $5,831,413 | 1.59% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Held | 1,469,153 | $5,612,164 | 1.53% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 1,139,363 | $5,218,282 | 1.42% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
Reduced | 216,171 | $2,754,018 | 0.75% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
NEW | 1,271,257 | $2,199,274 | 0.60% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Added | 1,438,159 | $605,464 | 0.17% | |
| BCAB |
BioAtla, Inc.
Healthcare
|
Reduced | 108,126 | $447,641 | 0.12% | |
| YARW |
Yarrow Bioscience, Inc.
Healthcare
|
Held | 1,425 | $927 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.